SEC Form 4 · accession 0001061983-17-000041
CYTOKINETICS INC · CYTK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ching Jaw
Officer — SVP Finance & CFO
Period of report
Jun 30, 2017
Accepted (ET)
Jun 30, 2017 · 7:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061983
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $12.10 | Jun 30, 2017 | A | 33,056 | A | Jun 30, 2018 | Jun 30, 2027 | Common Stock | 33,056 | 33,056 | D |
| Non-Qualified Stock Option (right to buy)F1 | $12.10 | Jun 30, 2017 | A | 41,944 | A | Jun 30, 2018 | Jun 30, 2027 | Common Stock | 41,944 | 41,944 | D |
Explanation of responses
- F1When the ISO and NQ dated 06/30/17 are combined for a total grant of 75,000 shares, the option shall vest and become exercisable as to 18,750 shares on 06/30/18 and the balance of 56,250 divided into equal monthly installments thereafter such that the option shall be 100% vested on 06/30/21.